Lophius Biosciences (Germany)

4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease†

Leo R. Fitzpatrick, Ludwig Deml, Claudia Hofmann et al. · Inflammatory Bowel Diseases · 2010 · 66 citations · Full text

An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity

Sascha Barabas, Theresa Spindler, Richard Kiener et al. · BMC Immunology · 2017 · 65 citations · Full text

Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation

Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke et al. · Haematologica · 2019 · 44 citations · Full text

Cell Therapy, Cytomegalovirus-specific Cellular Immunity, Immunodeficiencies +19

Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients

Bernhard Banas, Carsten A. Böger, Gerhard Lückhoff et al. · BMC Immunology · 2017 · 40 citations · Full text

Clinical validation of a novel enzyme-linked immunosorbent spot assay-based<i>in vitro</i>diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study

Bernhard Banas, Dominik Steubl, Lutz Renders et al. · Transplant International · 2017 · 37 citations · Full text